1
|
Lupu A, Stoleriu G, Nedelcu AH, Perju SN, Gavrilovici C, Baciu G, Mihai CM, Chisnoiu T, Morariu ID, Grigore E, Shawais SK, Salaru DL, Revenco N, Lupu VV. Overview of Oxidative Stress in Systemic Lupus Erythematosus. Antioxidants (Basel) 2025; 14:303. [PMID: 40227251 PMCID: PMC11939823 DOI: 10.3390/antiox14030303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2025] [Revised: 02/16/2025] [Accepted: 02/27/2025] [Indexed: 04/15/2025] Open
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease that is frequently diagnosed in female patients, caused by multiple interacting factors. It has a complex pathogenesis which can affect almost any organ, from the kidneys to the cardiovascular, pulmonary, neurological, osteoarticular, and hematological systems. The present narrative review seeks to elucidate the role of reactive oxygen species (ROS) in the pathogenesis of SLE. The central question guiding this study is to what extent these serum protein modifications correlate with disease activity and organ damage in SLE. It is characterized by the decreased apoptosis and increased necrosis of T cells and the NETosis of granulocytes. Given the impact of an SLE diagnosis on one's life, this narrative review aims to evaluate the intricacies of oxidative stress and its relevance to the pathogenesis and treatment of the disease. Topics such as understanding processes of oxidative stress, their damaging pathways, oxidative stress biomarkers, and their role in the future assistance of clinical decisions will be discussed in the article. The accurate determination of biomarkers is taught to improve both the diagnosis and the management of the disease, while antioxidant therapy may open a new door for the treatment.
Collapse
Affiliation(s)
- Ancuta Lupu
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania; (A.L.); (C.G.); (V.V.L.)
| | - Gabriela Stoleriu
- Clinical Medical Department, Faculty of Medicine and Pharmacy, “Dunarea de Jos” University of Galati, 800008 Galati, Romania; (G.S.); (G.B.)
| | - Alin Horatiu Nedelcu
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania (S.K.S.); (D.L.S.)
| | - Sara Nadeea Perju
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania; (A.L.); (C.G.); (V.V.L.)
| | - Cristina Gavrilovici
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania; (A.L.); (C.G.); (V.V.L.)
| | - Ginel Baciu
- Clinical Medical Department, Faculty of Medicine and Pharmacy, “Dunarea de Jos” University of Galati, 800008 Galati, Romania; (G.S.); (G.B.)
| | - Cristina Maria Mihai
- Pediatrics, Faculty of Medicine, “Ovidius” University, 900470 Constanta, Romania; (C.M.M.); (T.C.)
| | - Tatiana Chisnoiu
- Pediatrics, Faculty of Medicine, “Ovidius” University, 900470 Constanta, Romania; (C.M.M.); (T.C.)
| | - Ionela Daniela Morariu
- Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania;
| | - Ecaterina Grigore
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania (S.K.S.); (D.L.S.)
| | - Shwan Karwan Shawais
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania (S.K.S.); (D.L.S.)
| | - Delia Lidia Salaru
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania (S.K.S.); (D.L.S.)
| | - Ninel Revenco
- Pediatrics, “Nicolae Testemitanu” State University of Medicine and Pharmacy, 2004 Chisinau, Moldova;
| | - Vasile Valeriu Lupu
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania; (A.L.); (C.G.); (V.V.L.)
| |
Collapse
|
2
|
Lupu VV, Miron I, Trandafir LM, Jechel E, Starcea IM, Ioniuc I, Frasinariu OE, Mocanu A, Petrariu FD, Danielescu C, Nedelcu AH, Salaru DL, Revenco N, Lupu A. Challenging directions in pediatric diabetes - the place of oxidative stress and antioxidants in systemic decline. Front Pharmacol 2024; 15:1472670. [PMID: 39744134 PMCID: PMC11688324 DOI: 10.3389/fphar.2024.1472670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2024] [Accepted: 12/04/2024] [Indexed: 01/06/2025] Open
Abstract
Diabetes is a complex condition with a rising global incidence, and its impact is equally evident in pediatric practice. Regardless of whether we are dealing with type 1 or type 2 diabetes, the development of complications following the onset of the disease is inevitable. Consequently, contemporary medicine must concentrate on understanding the pathophysiological mechanisms driving systemic decline and on finding ways to address them. We are particularly interested in the effects of oxidative stress on target cells and organs, such as pancreatic islets, the retina, kidneys, and the neurological or cardiovascular systems. Our goal is to explore, using the latest data from international scientific databases, the relationship between oxidative stress and the development or persistence of systemic damage associated with diabetes in children. Additionally, we highlight the beneficial roles of antioxidants such as vitamins, minerals, polyphenols, and other bioactive molecules; in mitigating the pathogenic cascade, detailing how they intervene and their bioactive properties. As a result, our study provides a comprehensive exploration of the key aspects of the oxidative stress-antioxidants-pediatric diabetes triad, expanding understanding of their significance in various systemic diseases.
Collapse
Affiliation(s)
- Vasile Valeriu Lupu
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
| | - Ingrith Miron
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
| | | | - Elena Jechel
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
| | | | - Ileana Ioniuc
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
| | | | - Adriana Mocanu
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
| | | | - Ciprian Danielescu
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
| | - Alin Horatiu Nedelcu
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
| | - Delia Lidia Salaru
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
| | - Ninel Revenco
- Pediatrics, “Nicolae Testemitanu” State University of Medicine and Pharmacy, Chisinau, Moldova
| | - Ancuta Lupu
- Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania
| |
Collapse
|
3
|
Frăsinariu OE, Lupu VV, Trandafir LM, Streanga V, Jechel E, Bararu-Bojan I, Vasiliu I, Cuciureanu M, Loghin II, Mitrofan C, Nedelcu AH, Knieling A, Lupu A. Metabolic syndrome therapy in pediatric age - between classic and modern. From diets to pipeline drugs. Front Nutr 2024; 11:1475111. [PMID: 39723164 PMCID: PMC11669255 DOI: 10.3389/fnut.2024.1475111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2024] [Accepted: 11/18/2024] [Indexed: 12/28/2024] Open
Abstract
The metabolic syndrome, made up of the sum of the entities that define it (obesity, hypertension, dyslipidemias and non-alcoholic hepatic steatosis) has gained an important place in the research of the last decades. This aspect is mainly due to the complexity of management in pediatric practice. The main directions in his approach therefore bring together the concern of counteracting the noise or systemic, of the multiple intercurrents at the physiopathological level, as well as the negative imprint exerted on the quality of life. Its appearance and evolution are currently controversial topics, but the influence of genetic predisposition and lifestyle (diet, physical activity, psychological balance) are certainties. Considering the escalation of the incident at the global level, it is self-evident that it is necessary to know the pathogenesis and practice countermeasures for prophylactic or therapeutic purposes. The present work aims to summarize general aspects related to the metabolic syndrome encountered in pediatric age, with an emphasis on complementary therapeutic perspectives and their effectiveness, by analyzing the latest data from the specialized literature, accessed with the help of international databases (e.g., PubMed, Web of Science, Scopus, Embase, Google Scholar).
Collapse
Affiliation(s)
- Otilia Elena Frăsinariu
- Faculty of Medicine, Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Vasile Valeriu Lupu
- Faculty of Medicine, Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Laura Mihaela Trandafir
- Faculty of Medicine, Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Violeta Streanga
- Faculty of Medicine, Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Elena Jechel
- Faculty of Medicine, Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Iris Bararu-Bojan
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Ioana Vasiliu
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Magdalena Cuciureanu
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Isabela Ioana Loghin
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Costica Mitrofan
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Alin Horatiu Nedelcu
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Anton Knieling
- Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| | - Ancuta Lupu
- Faculty of Medicine, Pediatrics, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
| |
Collapse
|
4
|
Muhammad N, Ahad A, Rashid N, Gul R, Tariq MA, Nazir A. Assessing the Impact of Early Nutritional Intervention on Pediatric Celiac Disease Management: A Prospective Cohort Study. Cureus 2024; 16:e76059. [PMID: 39835063 PMCID: PMC11743799 DOI: 10.7759/cureus.76059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/20/2024] [Indexed: 01/22/2025] Open
Abstract
BACKGROUND Celiac disease is a chronic autoimmune condition requiring lifelong adherence to a gluten-free diet, particularly in children, to prevent nutritional deficiencies and developmental delays. OBJECTIVE The objective of study was to evaluate the effects of early nutritional intervention on the management and health outcomes of children diagnosed with celiac disease. METHODOLOGY A prospective, longitudinal cohort study was conducted over two years (July 2019-July 2021). A customized gluten-free meal plan and any necessary dietary supplements were given to the participants. Baseline evaluations and six-monthly follow-ups were used to gather data on growth, nutritional status, and dietary compliance. SPSS was used for the statistical analysis, and a significance threshold of p<0.05 was established. RESULTS Significant improvements were observed in growth metrics, with mean height increasing from 145.67 cm to 157.48 cm and weight from 36.29 kg to 46.24 kg over 24 months (p < 0.001). Nutritional status also improved, with serum iron levels rising from 45.19 µg/dL to 76.89 µg/dL and vitamin D from 20.14 ng/mL to 44.22 ng/mL (p < 0.001). Dietary adherence increased from 84.37% to 94.62%. CONCLUSION Growth and nutritional results in children with celiac disease are greatly improved with nutritional intervention.
Collapse
Affiliation(s)
- Naveed Muhammad
- Pediatrics, Khyber Teaching Hospital, Peshawar, PAK
- Pediatrics, Regional Hospital Mullingar, Mullingar, IRL
| | - Abdul Ahad
- Pediatrics, Ninewells Children's Hospital, Dundee, GBR
- Pediatrics, Hayatabad Medical Complex, Peshawar, PAK
| | - Nasar Rashid
- Pediatrics and Child Health, Hayatabad Medical Complex, Peshawar, PAK
- Pediatrics, Royal Hospital for Children and Young People, Edinburgh, GBR
| | - Rabia Gul
- Pediatrics, Khyber Teaching Hospital, Peshawar, PAK
- Pediatrics, Regional Hospital Mullingar, Mullingar, IRL
| | - Muhammad Arsalan Tariq
- Pediatrics, Hayatabad Medical Complex, Peshawar, PAK
- Pediatrics, Royal Aberdeen Children Hospital, Aberdeen, GBR
| | - Anam Nazir
- Medicine, Basic Health Unit 155/wb, Vehari, PAK
- Medicine, Bahawal Victoria Hospital, Bahawalpur, PAK
| |
Collapse
|